Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04492514 |
|---|---|
| Brief Title: | Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflation |
| First Submitted : | July 28, 2020 |
| First Submitted that Met QC Criteria : | July 28, 2020 |
| First Posted : | July 30, 2020 |
| Last Update Submitted that Met QC Criteria : | July 28, 2020 |
| Last Update Posted : | July 30, 2020 |